Biopolymeric 3D printed implantable scaffolds as a potential adjuvant treatment for acute post-operative pain management

Aikaterini Dedeloudi,Laura Martinez-Marcos,Thomas Quinten,Sune Andersen,Dimitrios A. Lamprou
DOI: https://doi.org/10.1080/17425247.2024.2336492
2024-04-02
Expert Opinion on Drug Delivery
Abstract:Background Pain is characterized as a major symptom induced by tissue damage occurring from surgical procedures, whose potency is being experienced subjectively, while current pain relief strategies are not always efficient in providing individualized treatment. 3D printed implantable devices hold the potential to offer a precise and customized medicinal approach, targeting both tissue engineering and drug delivery.
pharmacology & pharmacy
What problem does this paper attempt to address?
The main problem that this paper attempts to solve is the deficiencies of existing treatment strategies in postoperative acute pain management. Specifically, although traditional oral or intravenous opioid drugs are widely used, there are problems such as abuse, misuse and diversion, which have led to the opioid epidemic. In addition, these traditional treatment methods are not always effective in providing individualized treatment, especially in pain management caused by tissue damage after surgery. Therefore, this study aims to develop a new type of 3D - printed biopolymer implant scaffold as an adjuvant treatment for postoperative acute pain management. ### Research Background 1. **Challenges in Postoperative Pain Management**: - Traditional treatment methods such as oral or intravenous opioid drugs are effective, but there are risks of abuse, misuse and diversion. - These methods have limitations in providing individualized treatment, especially in the management of postoperative acute pain. 2. **Advantages of 3D Printing Technology**: - 3D printing technology can produce precise and personalized medical devices, which are suitable for tissue engineering and drug delivery. - Through 3D - printing technology, local and continuous drug release can be achieved, thereby improving the treatment effect and patient compliance. ### Research Objectives - **Develop 3D - printed biopolymer implant scaffolds**: Use polycaprolactone (PCL) and PCL - chitosan (CS) composites to prepare implant scaffolds loaded with procaine (PRC) through 3D - printing technology. - **Evaluate drug - release characteristics**: Study the release kinetics of PRC at different time points to achieve continuous pain management within 7 days after surgery. - **Optimize printing parameters**: Optimize the key process parameters (CPPs) in the 3D - printing process through thermal imaging, mechanical property testing and in vitro drug - release experiments to ensure the geometric structure integrity and mechanical strength of the scaffolds. ### Main Conclusions - **Physicochemical Stability and Mechanical Integrity**: Studies have shown that 3D - printed scaffolds have good physicochemical stability and mechanical strength. - **Drug - release Characteristics**: In vitro drug - release experiments have shown that CS is helpful for the continuous release of PRC, achieving drug release within 7 days. - **Potential Applications**: This 3D - printed implant scaffold is expected to become an effective adjuvant treatment for postoperative acute pain management, with the characteristics of low toxicity and continuous release. Through the above research, this paper aims to develop a new type of 3D - printed biopolymer implant scaffold to solve the deficiencies of existing treatment strategies in postoperative acute pain management and provide a safer and more effective treatment plan.